Add-on Acquisition • Life Science

Arbor Pharmaceuticals Acquires XenoPort

On May 23, 2016, Arbor Pharmaceuticals acquired life science company XenoPort for 467M USD

Acquisition Context

This is Arbor Pharmaceuticals’ 1st transaction in the Life Science sector.
This is Arbor Pharmaceuticals’ largest (disclosed) transaction.
This is Arbor Pharmaceuticals’ 1st transaction in the United States.
This is Arbor Pharmaceuticals’ 1st transaction in California.

Explore All 3110 Add-on Acquisition Life Science Deals - Search the Database Free

M&A Deal Summary
Date	May 23, 2016
Target	XenoPort
Sector	Life Science
Buyer(s)	Arbor Pharmaceuticals
Deal Type	Add-on Acquisition
Deal Value	467M USD
Advisor(s)	Centerview Partners (Financial) Weil Gotshal & Manges (Legal)

Target Company

XenoPort

Redwood City, California, United States

XenoPort, Inc. is a biopharmaceutical company focused on commercializing HORIZANT in the United States. XenoPort has entered into a clinical trial agreement with the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under which the NIAAA has initiated a clinical trial evaluating HORIZANT as a potential treatment for patients with alcohol use disorder.

Explore More Deals

Browse All 215,158 Deals

FILTER BY

Buyer Type (PE or Strategic)
Deal Size ($10M to $10B+)
Sector (60 Sectors)
Deal Type
Geography
& More

Search Free

Buyer Overview 1

Buyer

Arbor Pharmaceuticals

Atlanta, Georgia, United States

Category	Company
Sector	Life Science

DESCRIPTION

Arbor Pharmaceuticals is a specialty pharmaceutical company with a diversified portfolio of branded products across multiple therapeutic areas for the cardiovascular, pediatric, and hospital markets as well as generic products through its Wilshire division. Arbor Pharmaceuticals is based in Atlanta, Georgia.

Deal Context for Buyer	#
Overall	1 of 1
Sector: Life Science	1 of 1
Type: Add-on Acquisition	1 of 1
State: California	1 of 1
Country: United States	1 of 1
Year: 2016	1 of 1
Size (of disclosed)	1 of 1

Explore Related M&A Activity

Life Science M&A - Add-on Acquisition M&A Deals - California M&A - United States M&A - 2016 M&A